State Street Corp Logic Bio Therapeutics, Inc. Transaction History

State Street Corp

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	BUY	$3.85 - $5.09 $35,035 - $46,319	9,100 Added 36.68%	33,907 $155,000
Q2 2021 Aug 16, 2021	SELL	$4.03 - $7.57 $841,189 - $1.58 Million	-208,732 Reduced 89.38%	24,807 $110,000
Q1 2021 May 17, 2021	BUY	$6.8 - $9.16 $127,710 - $172,033	18,781 Added 8.75%	233,539 $1.7 Million
Q4 2020 Feb 16, 2021	BUY	$5.29 - $9.1 $302,021 - $519,546	57,093 Added 36.21%	214,758 $1.64 Million
Q3 2020 Nov 10, 2020	SELL	$5.41 - $9.45 $2,272 - $3,968	-420 Reduced 0.27%	157,665 $1.43 Million
Q2 2020 Aug 14, 2020	BUY	$4.25 - $8.46 $131,091 - $260,948	30,845 Added 24.24%	158,085 $1.34 Million
Q1 2020 May 11, 2020	BUY	$4.06 - $11.0 $516,594 - $1.4 Million	127,240 New	127,240 $629,000

Ticker LOGC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 32,962,700
Description
LogicBio Therapeutics, Inc., a genetic medicine company, focuses on developing and commercializing genome editing and gene therapy treatments using its GeneRide and sAAVy platforms. The company's GeneRide technology is a new approach to precise gene insertion harnessing a cell's natural deoxyribonucleic acid; and gene delivery platform, sAAVy is...

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

Stay updated on State Street Corp with notifications on news.